These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 8395681)
1. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8. Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681 [TBL] [Abstract][Full Text] [Related]
2. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells. Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882 [TBL] [Abstract][Full Text] [Related]
3. Both of the N-terminal and C-terminal regions of human papillomavirus type 16 E7 are essential for immortalization of primary rat cells. Yamashita T; Segawa K; Jimbow K; Fujinaga K J Investig Dermatol Symp Proc; 2001 Nov; 6(1):69-75. PubMed ID: 11764290 [TBL] [Abstract][Full Text] [Related]
4. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Liu Z; Ghai J; Ostrow RS; Faras AJ Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1. Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087 [TBL] [Abstract][Full Text] [Related]
6. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Banks L; Edmonds C; Vousden KH Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein. Caldeira S; de Villiers EM; Tommasino M Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of transformation by the human papillomaviruses. Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182 [TBL] [Abstract][Full Text] [Related]
9. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein. Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416 [TBL] [Abstract][Full Text] [Related]
10. [Experimental study on carcinogenesis by human papillomavirus type 8 E7 gene]. Nishikawa T Hokkaido Igaku Zasshi; 1994 May; 69(3):563-73. PubMed ID: 7927181 [TBL] [Abstract][Full Text] [Related]
11. Functional studies of E7 proteins from different HPV types. Ciccolini F; Di Pasquale G; Carlotti F; Crawford L; Tommasino M Oncogene; 1994 Sep; 9(9):2633-8. PubMed ID: 8058327 [TBL] [Abstract][Full Text] [Related]
12. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Brokaw JL; Yee CL; Münger K Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265 [TBL] [Abstract][Full Text] [Related]
13. Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells. Rumpf H; Esche H; Kirch HC Virology; 1999 Apr; 257(1):45-53. PubMed ID: 10208919 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166 [TBL] [Abstract][Full Text] [Related]
15. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression. Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Tan TM; Ting RC Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636 [TBL] [Abstract][Full Text] [Related]
19. Lack of immortalizing activity of a human papillomavirus type 16 variant DNA with a mutation in the E2 gene isolated from normal human cervical keratinocytes. Storey A; Greenfield I; Banks L; Pim D; Crook T; Crawford L; Stanley M Oncogene; 1992 Mar; 7(3):459-65. PubMed ID: 1312701 [TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity. Wong HK; Ziff EB J Virol; 1996 Jan; 70(1):332-40. PubMed ID: 8523545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]